Navigation Links
ARKRAY Statement Regarding U.S. Food and Drug Administration's Public Health Notification: Potentially Fatal Errors With GDH-PQQ Glucose Monitoring Technology
Date:8/14/2009

EDINA, Minn., Aug. 14 /PRNewswire/ -- ARKRAY, Inc., today announced that its line of GLUCOCARD and Assure blood glucose meter test strips do not use GDH-PQQ (glucose dehydrogenase pyrroloquinoline quinone), which the FDA has stated can falsely elevate blood glucose results in patients who are using certain therapeutic products.

The GLUCOCARD 01 and Assure families of products use a glucose-specific enzyme and can, therefore, distinguish between glucose and other sugars. In light of the FDA's announcement, ARKRAY will upgrade any consumer concerned about their GDH system to a product from the GLUCOCARD 01 family at no charge. For more information, visit www.glucocardusa.com or call 800-566-8558.

"We're very proud of our track record of safety and accuracy for our entire line of blood glucose monitoring products," said Jonathan Chapman, president of ARKRAY, USA. "ARKRAY is focused on developing safe, reliable and effective products and committed to patient safety. All of ARKRAY's blood glucose meters adhere to FDA requirements and are among the safest and most accurate on the market."

About ARKRAY USA

ARKRAY, the world's 5th largest manufacturer of diabetes self-monitoring systems, has been a pioneer for nearly 50 years in the field of automated analysis from laboratory and point-of-care systems to home use patient self-testing systems. ARKRAY's primary focus throughout that time has been diabetes, developing the world's first hand held blood glucose meter (late 1960s) and the world's first HbA1c analyzer (1982). ARKRAY is one of the few diabetes testing companies in the U.S. market today that undertakes in-house each step of the development process to bring products to market. ARKRAY is among the leading medical device companies noted for their patent-based intellectual property by Patent Board (Wall Street Journal 6/17/08). Worldwide, ARKRAY is the fifth largest blood glucose meter manufacturer. For more information, visit www.arkrayusa.com.


'/>"/>
SOURCE ARKRAY, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. ARKRAY USA Receives FDA Clearance on GLUCOCARD(R) 01-mini Blood Glucose Monitoring System
2. ARKRAY USA Nationally Launches GLUCOCARD(TM) X-METER Blood Glucose Monitoring System
3. Bayer Statement on U.S. Food and Drug Administration Advice for Patients: Serious Errors with Certain Blood Glucose Monitoring Test Strips
4. Statement from the American College of Surgeons Regarding Recent Comments from President Obama
5. ConvaTec Launches Versiva(R) XC(R) Campaign and Best Practice Statement
6. Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor (TNF) Blockers
7. Pelosi Statement on Energy and Commerce Committee Passage of Health Insurance Reform Legislation
8. Health Care Statement of Catholic Charities USA
9. Statement by Jim OHara, Director, Produce Safety Project, in Response to the FDAs Announcement Regarding Guidance on Produce Safety
10. Pew Statement on House Passage of Food Safety Legislation
11. Video: American Dental Association Statement: Food and Drug Administration Action on Dental Amalgam
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... ... The Radiology Business Management Association (RBMA) is pleased to announce ... process has been in place since the RBMA was founded in 1968 with all ... Jim Hamilton, MHA, CMM, FRBMA, as president. Dr. Dickerson the chief executive officer for ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... and College of Urgent Care Medicine will host industry leaders for the annual ... will help those in the industry adapt to the issues currently affecting urgent ...
(Date:4/28/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, has ... which He does not. Yisrayl says with so many titles and names for the ... he says with a little Scripture, backed with a lot of research, the truth is ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... skincare and advanced nutraceutical supplements, through its Nova Skin Sciences division, recently ... hydrating benefits of a moisturizer with the power of an anti-aging concentrate. ...
(Date:4/28/2017)... ... 2017 , ... Christie Medical Holdings, Inc. , with its market-leading ... Medical Inc. , a leader in infusion therapy and pain management. , Intravenous ... percent of hospital patients receiving a peripheral IV catheter as part of their treatment ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , Tenn. and DALLAS , April 19, ... Inc., announced that the first patients in ... EndoStim device in the Lower Esophageal Sphincter Stimulation for ... minimally-invasive implantable device designed to provide long-term reflux control ... GERD affects nearly 65 million people in ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-na├»ve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
(Date:4/18/2017)... 18, 2017 Research and Markets has announced ... report to their offering. ... global arthroscopy devices market to grow at a CAGR of 6.35% ... Devices Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. The report ...
Breaking Medicine Technology: